You have 9 free searches left this month | for more free features.

Dermatofibrosarcoma

Showing 1 - 25 of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dermatofibrosarcoma Protuberans Trial in Rochester (MOHS micrographic surgery, Wide local excision)

Completed
  • Dermatofibrosarcoma Protuberans
  • MOHS micrographic surgery
  • Wide local excision
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 4, 2020

Skin Tumors, Carcinoma, Basal Cell, Carcinoma, Squamous Cell Trial in Spain (Mohs surgery)

Completed
  • Skin Neoplasms
  • +6 more
  • Mohs surgery
  • Barakaldo, Spain
  • +14 more
May 4, 2020

Neuroblastoma, Rhabdomyosarcoma, Ewing's Sarcoma Trial in Worldwide (nab-paclitaxel)

Completed
  • Neuroblastoma
  • +22 more
  • Phoenix, Arizona
  • +19 more
Dec 19, 2019

Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma Trial in Canada, United States (saracatinib)

Completed
  • Adult Fibrosarcoma
  • +14 more
  • Rockledge, Pennsylvania
  • +3 more
May 29, 2018

Allergic Rhinitis, Vasomotor Rhinitis Trial in Luodong (Oral Levocetirizine, Combined Intranasal Mometasone Furoate with oral

Recruiting
  • Allergic Rhinitis
  • Vasomotor Rhinitis
  • Oral Levocetirizine
  • +2 more
  • Luodong, Yilan, Taiwan
    Camillian Saint Mary's Hospital Luodong
Apr 20, 2022

Familial Partial Lipodystrophy, Nonalcoholic Steatohepatitis, NAFLD Trial in Ann Arbor (Metreleptin)

Completed
  • Familial Partial Lipodystrophy
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan
Oct 30, 2020

Osteopenia, Osteoporosis Trial (Denosumab)

Completed
  • Osteopenia
  • Osteoporosis
  • Denosumab
  • (no location specified)
Nov 4, 2022

Hypereosinophilic Syndrome, Systemic Mastocytosis, Chronic Myelomonocytic Leukemia Trial in East Melbourne (imatinib mesylate)

Completed
  • Hypereosinophilic Syndrome
  • +3 more
  • imatinib mesylate
  • East Melbourne, Australia
    Novartis Investigative Site
Feb 21, 2017

Dyslipidemia Trial in Worldwide (Evolocumab, Placebo)

Completed
  • Dyslipidemia
  • Evolocumab
  • Placebo
  • Birmingham, Alabama
  • +1286 more
Jul 15, 2022

Lung Cancer, Non-Small Cell Trial in Worldwide (GSK1572932A Antigen-Specific Cancer Immunotherapeutic, Placebo Control)

Terminated
  • Lung Cancer, Non-Small Cell
  • GSK1572932A Antigen-Specific Cancer Immunotherapeutic
  • Placebo Control
  • Birmingham, Alabama
  • +619 more
Nov 27, 2020

Acromegaly Trial in Worldwide (Pasireotide LAR)

Completed
  • Acromegaly
  • Pasireotide LAR
  • Caba, Buenos Aires, Argentina
  • +49 more
Dec 6, 2019

Lateral Arm Flap Usage as Pedicle and Free Flap

Completed
  • Flap Necrosis
  • Lateral Arm Flap
  • Karachi, Sindh, Pakistan
    Aga Khan University Hospital
Dec 2, 2018

Plaque Psoriasis Trial in Worldwide (Ixekizumab, Placebo)

Completed
  • Plaque Psoriasis
  • Birmingham, Alabama
  • +124 more
Jun 10, 2020

Dermatofibrosarcomas of DARIER FERRAND(DFSP) Trial in Paris (Pazopanib)

Terminated
  • Dermatofibrosarcomas of DARIER FERRAND(DFSP)
  • Paris, France
    Hôpital Saint-Louis - Service de Dermatologie (Pole POPS)
Jun 30, 2016

Diabetes, Non-Insulin-Dependent, High Risk for Cardiovascular Event Trial in Worldwide (Dapagliflozin 10 mg, Placebo tablet)

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • High Risk for Cardiovascular Event
  • Dapagliflozin 10 mg
  • Placebo tablet
  • Alexander City, Alabama
  • +806 more
Dec 11, 2019

COPD, COPD, Moderate to Very Severe COPD Trial in Canada, United States (Aclidinium Bromide, Placebo)

Completed
  • COPD
  • +2 more
  • Aclidinium Bromide
  • Placebo
  • Birmingham, Alabama
  • +467 more
Nov 8, 2018

Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor, Adult Epithelioid Sarcoma Trial in United States (biological,

Completed
  • Adult Angiosarcoma
  • +34 more
  • Cixutumumab
  • +2 more
  • Chicago, Illinois
  • +12 more
May 16, 2016

Systemic Sclerosis Trial in New York (Imatinib Mesylate)

Completed
  • Systemic Sclerosis
  • Imatinib Mesylate
  • New York, New York
    Hospital for Special Surgery
Jan 9, 2018

Diabetes Trial in Worldwide (Albiglutide 30 mg, Albiglutide 50 mg, Albiglutide matching )

Completed
  • Diabetes Mellitus
  • Albiglutide 30 mg
  • +2 more
  • Birmingham, Alabama
  • +607 more
Feb 11, 2019

Life Threatening Diseases Trial (Imatinib mesylate)

Completed
  • Life Threatening Diseases
  • Imatinib mesylate
  • (no location specified)
Nov 16, 2016

Antibody Mediated Rejection Trial in Worldwide (Eculizumab)

Terminated
  • Antibody Mediated Rejection
  • Birmingham, Alabama
  • +40 more
Sep 4, 2017

Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor, Endometrial Cancer Trial in Boston, New York (sunitinib malate)

Completed
  • Adult Malignant Fibrous Histiocytoma of Bone
  • +5 more
  • sunitinib malate
  • Boston, Massachusetts
  • +1 more
Dec 15, 2015

Diabetes, Type 2 Trial in Worldwide (Exenatide (AC2993), Insulin glargine)

Completed
  • Diabetes Mellitus, Type 2
  • Exenatide (AC2993)
  • Insulin glargine
  • San Diego, California
  • +90 more
Mar 19, 2015

Breast Tumors Trial in United States (exemestane (Aromasin), tamoxifen + exemestane)

Completed
  • Breast Neoplasms
  • exemestane (Aromasin)
  • tamoxifen + exemestane
  • Bessemer, Alabama
  • +178 more
Oct 6, 2015

Sarcoma Trial in Duarte (genetic, procedure, radiation)

Terminated
  • Sarcoma
  • gene expression analysis
  • +5 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 12, 2014